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Abstract
Recombination is a common feature of many positive-strand RNA viruses, playing an impor-
tant role in virus evolution. However, to date, there is limited understanding of the mecha-
nisms behind the process. Utilising in vitro assays, we have previously shown that the
template-switching event of recombination is a random and ubiquitous process that often
leads to recombinant viruses with imprecise genomes containing sequence duplications.
Subsequently, a process termed resolution, that has yet to be mechanistically studied,
removes these duplicated sequences resulting in a virus population of wild type length
genomes. Using defined imprecise recombinant viruses together with Oxford Nanopore and
Illumina high throughput next generation sequencing technologies we have investigated the
process of resolution. We show that genome resolution involves subsequent rounds of tem-
plate-switching recombination with viral fitness resulting in the survival of a small subset of
recombinant genomes. This alters our previously held understanding that recombination
and resolution are independent steps of the process, and instead demonstrates that viruses
undergo frequent and continuous recombination events over a prolonged period until the fit-
test viruses, predominantly those with wild type length genomes, dominate the population.
Author summary
Viruses with positive-sense RNA genomes, such as poliovirus, have several mechanisms
by which they evolve. One of these is the process of recombination involving the large-
scale exchange of genetic information. Recombination occurs during replication when the
viral polymerase, bound to the nascent RNA chain, switches from copying one genome to
another. However, the polymerase does not always accurately switch between the two,
resulting in sequence duplications or deletions, and genomes that are referred to as impre-
cise. Over multiple rounds of replication sequence duplications are lost and genomes are
resolved to wild type length, but it is unclear how this occurs. Here we used synthetic
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polioviruses containing defined sequence duplications to determine that the genome pop-
ulation undergoes repeated rounds of recombination until sequence duplications are lost
and viruses with precise, wild type length genomes are selected for. This selection is based
on the overall fitness of the virus population, with less fit imprecise viruses evolving more
quickly. Our study suggests that recombination is a continual process where virus fitness
drives the selection of a small subset of recombinant variants. These data are important
for understanding how novel viruses evolve via recombination and how this process can
be blocked to prevent novel and dangerous pathogens from arising.
Introduction
RNA viruses usually exist as quasispecies due to error-prone RNA-dependent RNA polymer-
ases (RdRps) which misincorporate nucleotides during genome replication. In many RNA
viruses, the process of recombination generates additional diversity within the virus popula-
tion. Recombination allows for a larger exchange of genetic material between closely related
viruses and is proposed to be a mechanism by which genomes can be rescued from error catas-
trophe, which would otherwise have resulted from the accumulation of deleterious mutations
introduced by the RdRp [1–3]. Recombination is widely accepted to occur via a copy-choice
mechanism involving the RdRp switching from one template (the donor) to another (the
acceptor) during negative-strand synthesis [4]. Sequence identity and RNA structure have
been proposed to influence the template-switching event, although evidence is often contradic-
tory and may reflect analysis of highly selected populations (reviewed in [5]).
Poliovirus, the prototype species C enterovirus of the Picornaviridae family, has proven to
be a useful tool for the study of recombination. It has long been known that the three serotypes
frequently recombine [6,7] and there are well-established reverse genetic techniques allowing
markers for recombination to be engineered into the genome [8,9]. Poliovirus, like all entero-
viruses, has a positive-strand RNA genome of approximately 7.5 Kb. The genome encodes a
single polyprotein flanked by 50 and 30 untranslated regions (UTR) containing the signals for
translation and replication. The polyprotein is co- and post-translationally cleaved to yield the
structural proteins (P1: VP4, VP3, VP2, VP1) and the non-structural proteins (P2: 2Apro, 2B,
2C and P3: 3A, 3BVPg, 3Cpro and 3Dpol).
We have developed an in vitro recombination assay–the poliovirus CRE-REP assay–that
solely generates recombinant progeny viruses [10]. The CRE-REP assay requires co-transfec-
tion of two RNA molecules that independently cannot generate viable virus progeny; (1) a
poliovirus serotype 1 (PV1)-based replicon in which the structural proteins have been replaced
with a luciferase marker gene, and (2) a full-length poliovirus serotype 3 (PV3) genome in
which the 2C cis-acting replication element (CRE; [11]) has been mutated so that the virus can
no longer synthesise new positive-strand genomes [12]. When co-transfected into permissive
cells the two non-infectious genomes produce negative strands, which can recombine to yield
a population of viable recombinant viruses. Using this assay, we postulated that recombination
is a biphasic process [10]. First, an RdRp strand-transfer event produces genomes that may
contain sequence duplications of up to several hundred nucleotides. The imprecise and appar-
ently random nature of this recombination event argues strongly against sequence identity or
structure being a major influence [13]. Since in vivo recombination results in genome-length
products we proposed that strand transfer is followed by a second event we termed resolution,
in which sequence duplications are lost via an iterative process. This could be demonstrated
experimentally in vitro [10]. Resolution results in a virus population containing a variety of
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precise junctions between donor and acceptor templates [10]. Mechanistically the process of
resolution is poorly defined, but two obvious scenarios can be envisaged: an in-cis internal
deletion event involving individual genomes or an in-trans process requiring two or more
genomes (Fig 1).
In recent studies involving the next generation sequencing of whole cell RNA prepara-
tions from co-infected cells, and parallel CRE-REP assays using highly modified templates,
we provide further evidence that recombination per se (the strand transfer event) is not
influenced by either the RNA donor or acceptor sequence or its structure [13]. At face
value this contradicts numerous studies of recombinant virus genomes which have impli-
cated local RNA structure, sequence identity or particular nucleotides at the recombination
junction [14–20]. However, progeny recombinant virus genomes in these studies are likely
to have undergone one or many rounds of resolution and, in contrast to the initial recom-
binant viral RNA population in the cell cytoplasm, are–by definition–functionally intact
and packaged into infectious virus.
It therefore remained a possibility that recombination and resolution are mechanistically
dissimilar events, in which case sequence identity, composition or structure might influence
one and not the other. To address this we used a well-characterised imprecise recombinant
genome, #105B a type 1/3 poliovirus recombinant containing a 249 nt genome duplication
[10], to investigate resolution independently of the initial template-switching event of recom-
bination. We demonstrate that resolution of the virus population is driven by viral fitness and
is enhanced in the presence of ribavirin, a mutagen that decreases RdRp fidelity and has previ-
ously been demonstrated to enhance recombination [10]. In addition, we characterised the
resolving/resolved virus population following co-infection of uniquely barcoded imprecise
recombinant viruses. We determined that resolution is, at least in part, a process requiring fur-
ther template-switching/recombination events. The biphasic recombination process therefore
appears to involve iterative strand-transfer events in which the primary determinant of selec-
tion is the fitness of the resulting virus genome.
Results
Rate of resolution is influenced by virus fitness
To better understand the resolution process, we investigated whether resolution was influ-
enced by the sequence background of the imprecise recombinants studied to date. We have
previously identified and subsequently constructed a cDNA for a viable intertypic (PV3/
PV1) imprecise recombinant designated, #105B (GenBank MZ165620). The #105B cDNA
has a 249 nt sequence insertion at the VP1/2A cleavage boundary consisting of duplicated
VP1 and 2A sequences, as well as a fragment of firefly luciferase sequence derived from the
sub-genomic replicon used in the CRE-REP assay in which #105B was generated (Fig 2A,
upper panel) [10].
We reasoned that any in cis resolution events might be influenced by sequence identity
even if the original strand transfer event had not been. We therefore generated an intratypic
(PV3/PV3) version of #105B for comparison, designated #PV3-105B, containing an identical
sequence duplication to that of #105B but in a sequence background of PV3 only (Fig 2A,
lower panel; GenBank MZ165621). One-step growth curve analysis of #105B and #PV3-105B
showed a small but significantly lower (P<0.05, t-test) average maximum titre of 4.9x107 pfu/
ml for #105B when compared to 2.2x108 and 6x108 pfu/ml for parental viruses PV3 and PV1
respectively (Fig 2B). In contrast, we observed no statistically significant loss in replication fit-
ness of #PV3-105B, with a maximum virus titre of 3.3x108 pfu/ml. While maximum virus titres
are only one determinant of virus fitness in tissue culture–and may not be truly representative
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of virus replication in the gut–this suggests that sequence duplications alone may not have an
observable effect on virus fitness. This is contrary to our original finding that imprecise recom-
binants with duplications have an associated fitness cost.
We next tested whether these differences in the magnitude of replication influenced the
rate of resolution of the two imprecise recombinant viruses. Duplicate samples of #105B and
#PV3-105B were serially passaged 15 times (p1-15) on HeLa cells and the region spanning the
imprecise recombination site was amplified by RT-PCR from cell culture supernatant at each
passage (Fig 2C). Resolution of imprecise recombinants is reflected in the increased gel mobil-
ity of the PCR fragment spanning the recombination site, as deletions accumulate in the virus
Fig 1. Model of recombination and resolution. Recombination initially occurs as an in trans template-switching event between two parental viruses
(represented by numerical genome schematics). This event generates a mixed population of viruses containing a variety of imprecise recombinants with
sequence duplications, as represented by the duplicated numbers of the schematic genomes. The pool of imprecise recombinants subsequently undergoes
resolution where these duplications may be lost via an, as yet undetermined, in cis deletion process or via further rounds of in trans template-switching
recombination events.
https://doi.org/10.1371/journal.ppat.1009676.g001
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population. By p13, #105B had resolved to yield a single visible product representative of
viruses with genomes of native ‘wild type’ length. In contrast, with #PV3-105B, which when
resolved is indistinguishable from PV3, a minor product representing a greater-than-genome-
length virus population was observable alongside resolving products up to, and including, p15.
In both assays DNA products of intermediate size between unresolved and fully resolved prod-
ucts were visible. These were most prominent between p8 and p11 for #105B, and p9 and p11
for #PV3-105B (Fig 2C) and their gradual disappearance was suggestive of either an iterative
resolution process or that they were ‘dead-end’ products subsequently out-competed in the
virus population.
Analysis of the growth kinetics for the resolved #105B virus population (#105B-R) at p15
showed restoration of parental levels of virus replication, with a peak virus titre of 2.1x108 pfu/
ml (Fig 2B). This demonstrated that at the population level, resolution is in part driven by
virus replication fitness, with fitter imprecise viruses, i.e., #PV3-105B, under less selective pres-
sure. We would therefore expect fitter imprecise recombinants to persist in the population for
longer than those with a replication defect.
Resolution of a clonal recombinant virus generates a diverse virus
population
We have previously reported apparently intermediate products in the resolution process [10]
similar to the transient PCR products that appeared between p8 and p11 during the resolution
of #105B and #PV3-105B (Fig 2C). To characterise these intermediate products in greater
detail and so gain a better understanding of the overall virus population during resolution, we
Fig 2. Phenotypic characterisation of intra- and intertypic imprecise recombinants. (A) Schematic representation of the genomes of
imprecise recombinants #105B and #PV3-105B. Regions in dark grey are derived from PV3 and regions in light grey are derived from
PV1. (B) Replication kinetics of imprecise clones. HeLa cells were infected with virus stock at multiplicity of infection of 5 and virus-
containing supernatants harvested over 24 h. Virus titres were determined by plaque assay on HeLa cells. Error bars represent the
standard deviation of 3 experiments. (C) Resolution of imprecise recombinant clones. Both #105B (upper panel) and #PV3-105B (lower
panel) were serially passaged on HeLa cells for 15 passages. Viral RNA was extracted from supernatants and the potential region of
recombination amplified by RT-PCR. The WT lane represents the 1470 nt product generated from a correct-genome length sample.
https://doi.org/10.1371/journal.ppat.1009676.g002
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utilised Oxford Nanopore Technologies (ONT) high throughput sequence analysis of both
#105B and #PV3-105B.
We selected individual or pooled passaged samples that would best represent the unre-
solved (p1) and intermediate resolved (#105B, p8-11; #PV3-105B, p10-13) populations. We
also analysed #105B and #PV3-105B at p15. Furthermore, to investigate how a population that
appears to be resolved may continue to evolve over time we additionally passaged #105B to
p18 and included this population in the analysis.
An amplicon library was prepared according to Oxford Nanopore protocols for 1D analy-
sis. The library consisted of uniquely barcoded PCR products, generated by amplifying a ~1.74
Kb region spanning the resolution window (see Materials and Methods), and representing the
unresolved, intermediate, and resolved virus populations (S1 Table). The library was prepared
such that those populations predicted to contain the most diversity in the range of recombi-
nant sequences generated, had greater representation within the library.
Two independent libraries were generated, one for each set of passaged samples, and
sequenced separately (reads available at SRA, BioProject PRJNA731157). For the analysis we
opted to focus only on genomes that could yield viable infectious progeny virus, i.e., those in
which any deletion still maintained the open reading frame. Any one deletion, however, could
occur anywhere within the duplicated region of the resolution window spanning nts 3361–
3720 (Fig 2A). Theoretically there were 14,209 possible deletions that fulfilled these criteria.
These were created in silico and used as reference templates for alignment of the ONT reads
(S1 Fig; and see Materials and Methods). After optimising the alignment of individual reads to
the template population, individual consensus sequences were generated representing the
resolving or resolved genomes within the virus population (S1 Fig).
As expected, the p1 populations for both #105B and #PV3-105B yielded single consensus
sequences matching the input virus, supporting the validity of the analysis pipeline. In all other
populations recombinant variants were designated as either fully resolved (i.e., the overall
genome length was identical to that of the parental viruses due to the acquisition of a 249 nt
deletion) or partially resolved (i.e., intermediate products in which some of the original 249 nt
duplication was retained). Fully resolved, precise junctions for #105B were designated after the
nucleotide position at which the recombinant genome sequence switched from matching the
50 PV3 sequence to the 30 PV1 sequence, with recombinants designated as the last nucleotide
matching PV3 (e.g., PV33378). However, due to sequence identity (81%) between PV3 and PV1
in this region there was often ambiguity as to the exact crossover point, as previously described
for such precise junctions [10]. Resolution to a precise junction required the deletion of 249
nt, which, to remain viable, must include the 137 nt of luciferase sequence derived from the
PV1 donor. The remaining 112 nt, encompassing duplicated regions of VP1 and 2A, could be
deleted from either the PV1 donor-derived or PV3 acceptor-derived sequence (resolution win-
dow; Fig 2A). Consequently, a precise junction could theoretically occur at any one of these
112 nt positions. However, due to the level of sequence identity between PV1 and PV3 in the
VP1/2A duplicated region only 23 precise junctions could be unambiguously defined. As fully
resolved #PV3-105B is indistinguishable from parental PV3, precise junctions could not be
defined. In comparison, recombinants of both #105B and #PV3-105B maintaining even a
small sequence duplication could inevitably be determined more accurately. These partially
resolved variants were designated by the number of nucleotides deleted from the initial 249 nt
duplication (e.g., #105BΔ162).
Despite the high numbers of theoretical recombinants, analysis of the #105B populations
detected only seven partially resolved (Fig 3A) and eight fully resolved (Fig 3C) unique junc-
tions (S2 Fig and S2 Table). Despite ~32% of the total ONT reads being generated to the par-
tially resolved #PV3-105B samples, only 3 unique junctions (#PV3-105BΔ231, -Δ225 and
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-Δ192) were present with sufficient frequency to generate representative consensus sequences
(Fig 3B). Notably, a few junctions were conserved in both #105B- and #PV3-105B-derived
resolving samples; #105BΔ225 and #105BΔ192 have identical deletion sizes and junction posi-
tions to #PV3-105BΔ225 and #PV3-105BΔ192. In addition, #105BΔ231 and #PV3-105BΔ231
contain an identically sized deletion, although the junctions are in different genome locations
(S2 Fig).
Considerable overlap was observed in both the resolved and partially resolved genomes
detected between the independently generated and analysed samples derived from #105B
Fig 3. Nanopore analysis of #105B and #PV3-105B recombinant populations. The sequences of viable recombinant
genomes were determined by consensus generation from Oxford Nanopore reads from all #105B and #PV3-105B
passaging populations sequenced. Partially resolved genomes are shown for (A) #105B and (B) #PV3-105B. The
original genome is shown at the top, where regions in dark grey are derived from PV3 and regions in light grey are
derived from PV1, and an expanded view of the duplicated region shown below. Individual recombinants are denoted
blue boxes with dashed lines representing the region of the duplication that has been lost. Numbers on the left-hand
side represent the number of nt deleted from the 249 nt required to fully resolve the genome. Underlined recombinant
names indicates recombinants detected in both replicate samples. (C) Resolved variants of #105B. Top schematic
represents the genome of #105B with an expanded view of the VP1/2A region expected for a resolved recombinant.
Resolved variants are represented by dual-coloured lines with sequence from PV3 in dark grey and sequence from PV1
in light grey. Red boxes denote the location of the resolved junction. Recombinant names, denoting the junction
position, are given on the left. Underlined recombinant names indicates recombinants detected in both replicate
samples.
https://doi.org/10.1371/journal.ppat.1009676.g003
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(Fig 4). Four of the fully resolved sequences (PV33378, PV33411, PV33420 and PV33456) and five
of the partially resolved sequences (#105BΔ246, -Δ231, -Δ225, -Δ207 and -Δ192) were identi-
fied in both independent replicates. Despite this overlap, the frequencies at which particular
variants were observed was not necessarily constant between replicates. We used consensus
generation–which is based on ONT read number–as a proxy measure for variant frequency
and plotted the relative percentages of each variant during the latter stages of passaging (S3
Fig). Based on the passaging methodology–where only 25% of supernatant was used to infect
Fig 4. Comparison of recombinants identified between #105B nanopore replicates. Each recombinant variant
identified from Oxford Nanopore analysis of the three #105B populations, p8-11, p15 and p18, are denoted as either
present (purple) or absent (yellow) from passaging replicates (R) 1 and 2.
https://doi.org/10.1371/journal.ppat.1009676.g004
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subsequent passages–we may expect to observe a bottleneck in the population based not only
on variant fitness, but also due to low-level variants not being transferred to the next passage.
For example, resolved variant PV33456 represented 3% and 19% of the population at p15 for
replicate 1 and 2 respectively. However, by p18 this variant was no longer detected in replicate
1, but had increased to 21% of the population for replicate 2. This suggests that in replicate 1
this virus was either not transferred upon passage, due to its initial low prevalence, or was
potentially rapidly outcompeted by other variants acquired simultaneously.
Unexpectedly, we identified the presence of several partially resolved variants at p15. Products
representative of these variants were not visible during gel analysis (Fig 2C, upper panel); however,
this is most likely a consequence of the limited sensitivity of the gel analysis technique. A subset of
these partially resolved variants also continued to be present at p18, indicating that even seemingly
resolved populations may be continually evolving alongside recombinant variants with non-wild
type length genomes. It is important to note that repeated passaging may also lead to the incorpo-
ration of point mutations through the natural error rates of the viral RdRp. It has previously been
demonstrated that the normal mutation rate for poliovirus is 2.1 per 10,000 nt [21] and such
mutations elsewhere in the genome may be beneficial for virus fitness, thus influencing the growth
of particular variants and therefore the overall resolving population. The presence of such muta-
tions may help to explain why some partially resolved variants remain at P18 and is similar to the
generation of quasispecies observed for HCV (reviewed in [22]).
While strict selection criteria were applied to the data to minimize errors in recombinant
junction or genome prediction caused by the high ONT error rate [23], these results suggest
only a limited number of the theoretical viable variants were either generated or replicated to
detectable levels during sequential virus passage. The similarities between partially resolved
variants of #105B and #PV3-105B also suggested that specific recombinants were favoured
regardless of the sequence of the backbone virus. As this was surprising, we used traditional
Sanger sequencing to provide an independent analysis of the resolving population to deter-
mine that the ONT consensus sequences generated were accurate representations of the
genomes extant in the virus population. Following PCR cloning, individual virus sequences
were isolated from p9 and p18 of #105B, and p10 for #PV3-105B. Of the 20 clones analysed we
were able to identify resolved variants PV33365 and PV33399, and partially resolved variants
-Δ246, -Δ231, -Δ225 and -Δ192 from #105B, and partially resolved variant -Δ192 from #PV3-
105B. Since these junctions were also all identified in the ONT analysis we concluded that con-
sensus generation in the latter was representative of the underlying population of resolving
recombinant molecules.
Analysis of resolution by Illumina sequencing
The analysis of the resolving virus population by ONT showed it has significant promise in the
study of recombination. For example, the long-read lengths enabled unresolved, partially
resolved and fully resolved genomes to be detected in a single population. However, the high
error rate inherent in ONT sequencing necessitated the use of strict criteria during pre-screen-
ing of primary data for consensus generation, including a threshold number of reads needed
to form the consensus (see Materials & Methods). Inevitably this reduced sensitivity which we
suspected resulted in missing less frequent resolving intermediates. In a recent study of recom-
bination we had used paired-end Illumina sequencing to detect recombination junctions
within total cell RNA. In this we were able to detect a much greater range of crossover junc-
tions in the RNA population than were present in the resulting recombinant infectious virus
population [13]. We therefore applied this method to investigate the process of resolution and
to compare with results from the ONT analysis.
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The imprecise recombinant #105B was passaged on HeLa cells until complete cytopathic
effect (CPE) was observed for each cell monolayer, whereupon total RNA samples were har-
vested for subsequent RT-PCR and agarose gel analysis of the duplicated region as above.
Under the conditions used in this assay, resolving genomes were apparent by p4 and resolution
appeared near-complete by p10. After two further passages the virus populations from pas-
sages p2, p7 and p12 were selected for further analysis. In addition, a p0 sample–obtained fol-
lowing transfection of RNA–was analysed to determine the population diversity detectable
prior to passaging. In contrast to the ONT analysis, which involved alignment to in-frame tem-
plates generated in silico, no constraints were placed on the resolving sequence junctions in
the Illumina dataset which were identified using a bioinformatics pipeline based on ViReMa
[13,24,25] (S4 Fig; reads available at SRA, BioProject PRJNA731157).
The unpassaged p0 population, harvested 24 h post-transfection was not clonal, but instead
contained a range of resolved precise deletions, together with additional genomes bearing
imprecise insertions or deletions (Fig 5A). By p2, the total amount of variation within the
sequenced population had markedly increased, with subsequent decreases at p7, and again at
p12 (Fig 5A and 5B). Changes in population diversity followed a similar pattern when mea-
sured both as the number of previously undetected unique junctions identified at each passage
(Fig 5B), and as a measure of Shannon Entropy (S5 Fig). The level of #105B within the popula-
tion was also reduced following each passage, as expected for the process of resolution (Fig
5B). A significant proportion of the junctions identified by VirReMa within the Illumina data-
set were out-of-frame (~30–50% in p0, p2 and p7), with the proportion dropping to ~10% by
p12 (Fig 5C).
It was clear from the p0 data that, if resolution is a stepwise process, it can occur extremely
rapidly as all of the 23 fully resolved variant genomes that can be unambiguously identified (as
Fig 5. Visualisation of #105B Illumina recombinant type. (A) Recombinants detected via Illumina sequencing were plotted by type for
p0, p2, p7, and p12; precise (open black circles), imprecise-insertion (open blue circles) or imprecise-deletion (open red circles). All
recombinants detected with Oxford Nanopore as well as Illumina sequencing, irrespective of passage number, are indicated as precise
(open black triangles) or imprecise-insertion (open blue triangles) recombinants. (B) Recombinant counts. The total number of
independent junctions at each passage (left Y axis) was plotted against the passage number (x-axis) highlighting the level of diversity
within the population at each passage. The proportion of #105B at each passage was plotted as a percentage of the total reads for #105B at
p0 and after normalisation of all reads to p0 (right Y axis). (C) Comparison of the percentage of in-frame and out-of-frame
recombinants present at each passage.
https://doi.org/10.1371/journal.ppat.1009676.g005
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discussed above) could be detected within the 24 h period between RNA transfection and
RNA extraction of the p0 sample. During subsequent passage the number of resolved variants
detected fell from 23 at p0 to 15 at p12, presumably as the fittest variants came to dominate the
population.
Overall, the Illumina sequence analysis of the RNA population during resolution revealed a
comparable abundance, variety, and distribution of recombinant genomes as we identified
during our study on recombination [13], indicating the same, or similar, mechanisms may
underpin both processes.
Ribavirin increases rate of resolution
RNA polymerase fidelity is a major determinant of recombination [10,26], with error-prone
RdRp variants generating recombinants at an increased frequency [27,28]. One way to increase
the error-rate of the native polymerase is to introduce sub-lethal concentrations of ribavirin, a
well characterised guanosine analogue which induces base mismatches when incorporated
into the viral genome and, at high levels, results in lethal mutagenesis by error catastrophe
[21]. We have previously demonstrated that ribavirin increases the yield of recombinants in
the CRE-REP assay by ~300% [10]. If the process of resolution also involves additional rounds
of recombination or is influenced by the error-rate of the RdRp, we predicted that the presence
of ribavirin would also increase the rate of resolution.
We therefore serially passaged #105B, recovered following transfection with in vitro pro-
duced RNA, in the presence of a range of sub-lethal concentrations of ribavirin and monitored
the resolving population by RT-PCR. There was a clear dose-response with increasing levels of
ribavirin resulting in the more rapid appearance of a fully resolved product with increased
mobility when analysed by agarose gel electrophoresis (Fig 6). In addition, the presence of the
large unresolved parental #105B product–still apparent at passage 10 in the absence of
Fig 6. The rate of resolution of #105B increases in the presence of Ribavirin. #105B was serially passaged ten times
on HeLa cells in the presence of 0, 50, 100 or 200 μM of ribavirin. Viral RNA was extracted, amplified by PCR and
analysed by gel electrophoresis. WT = PV3, representing genome-length product. M = GeneRuler 1kb plus DNA
markers (FisherScientific).
https://doi.org/10.1371/journal.ppat.1009676.g006
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ribavirin–was also influenced by increasing concentrations of ribavirin, being lost by p5 or p4
with 100 μM or 200 μM ribavirin respectively. These results indicate that the process of resolu-
tion is influenced by the error rate of the viral polymerase and is at least suggestive that further
rounds of in trans recombination might be involved in resolution. To investigate the latter fur-
ther we explored the generation of recombinant genomes during the resolution of uniquely
barcoded variants of #105B.
Recombination is detected during resolution of barcoded viruses
The structure of the #105B genome means that all partially or fully resolved derivatives must
effectively ‘lose’ sequences from within the resolution window. We therefore introduced modi-
fications flanking this region that would allow the detection of resolving genomes that could
only have arisen following a recombination event (Figs 2A and 7A). Taking advantage of the
degeneracy of the triplet amino acid code we synthesised a small panel of synonymous variants
encompassing five-codons on each side of the resolution window. Individual viruses were
recovered from engineered cDNAs using standard techniques and their growth kinetics com-
pared in parallel to #105B. Two uniquely barcoded cDNAs designated #105BT1 and #105BT2
(Fig 7A), encoding viruses with replication kinetics indistinguishable from the parental #105B
(Fig 7B) were chosen for further study.
HeLa cells were co-infected with #105B and either #105BT1 or #105BT2 at a 1:1 ratio of each
virus and a final MOI of 10. Virus was harvested and serially passaged, with each passage titred
to maintain the MOI of 10 in order to maximise the likelihood that each cell would be infected
with at least one copy of each #105B variant. Resolution was monitored by RT-PCR amplifica-
tion of the resolution window (and flanking barcodes), and 48 individually cloned PCR
Fig 7. Characterisation of barcoded #105B. (A) Schematic representation of the sequences modified in #105B for the addition
individual barcodes. (B) Replication kinetics of #105B and barcoded viruses.
https://doi.org/10.1371/journal.ppat.1009676.g007
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products from resolving, or resolved, populations were sequenced for each of the two co-infec-
tions (n = 96).
Of the 96 sequences 89 consisted of a single clonal population, with the remaining 7 being
mixed and excluded from further analysis. Of the 89 clonal sequences, 76 (85%) were unre-
solved (n = 5), partially resolved (n = 53) or completely resolved (n = 18) with flanking barcode
regions matching only one or other of the parental viruses. These neither supported nor
refuted an involvement for recombination in the resolution process as the resolved genomes
could have been generated by recombination between identical parental viruses or via an in cis
deletion process. However, the remaining 13 sequences (15%), all of which were partially
(n = 11) or completely (n = 2) resolved, contained mismatched sequences in the barcoded
regions indicative of a recombination event. Four of these 13 sequences were biological dupli-
cates, leaving a total of 9 unique resolving genomes that must have arisen from a recombina-
tion event (Fig 8 and S3 Table). Interestingly, 2 of the junctions identified–partially resolved
-Δ207 and fully resolved PV33420 –were identical to junctions previously observed when pas-
saging #105B (compare Fig 3A and 3C to Fig 8), with -Δ207 also being detected from both bar-
coded co-infections. This observation was in agreement with the commonality of junctions
observed between replicates of the #105B ONT analysis and again, implies that a limited
Fig 8. Analysis of barcoded #105B recombinants. Schematic representation of unique recombinant variants identified following co-
infection of #105B with barcoded virus #105BT1 or #105BT2, and passage on HeLa cells until resolution was observed. Sequence names
are given on the left with the top three, #105B, #105BT1 and #105BT2, representing parental constructs with modified sequences flanking
the resolution window represented by a triangle (#105BT1) or a circle (#105BT2). Fully resolved or partially resolved sequences are
shown with a dashed line representing the region that has been lost from the parental sequence, with appropriate shapes denoting the
parental construct from which the 50 and 30 sequences were derived.
https://doi.org/10.1371/journal.ppat.1009676.g008
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number of resolving variants are detected from infectious virus supernatant, despite the abun-
dance of variants at the RNA level [13]. Taken together these data confirm that resolution
occurs, at least in part, via further rounds of template-switching events.
Discussion
The evolution of RNA viruses with single-stranded, positive-sense genomes is, in large part,
driven by the process of recombination. This process can overcome the effects of deleterious
mutations on individual genomes, thus continuing to provide the population diversity
required to prevent error catastrophe [29], while also resulting in the generation of novel
viruses with potentially novel phenotypes [30,31]. The mechanisms underpinning recombina-
tion have not been well characterised, but initial polymerase template-switching events fre-
quently result in the insertion or deletion of genomic sequence, referred to as imprecise
junctions [10]. We have previously demonstrated that viruses with imprecise insertions in the
genome undergo a process–termed resolution–that leads to the loss of duplicated sequences
and the creation of recombinant viruses with precise junctions and native or ‘wild type’ length
genomes [10].
Recombination has previously been linked to the presence of RNA structures and/or
regions of sequence identity [15–17,19,32–34], although there are a number of contradictory
reports regarding the exact influence of such factors [18,20,35]. The majority of published
studies on recombination have focused on analysing the end results of recombination i.e.,
viruses with wild type length genomes. If resolution is a distinct process from recombination,
then it may be that the sequence and structure dependencies observed are a result of this sec-
ond process and not the initial polymerase template-switching event. In the current study, we
have therefore investigated this process of resolution in order to understand it better.
Throughout this study we have made use of a previously cloned imprecise intertypic type 3/
1 poliovirus recombinant–#105B –containing a 249nt insertion spanning the P1/P2 junction
boundary (Fig 2) [10]. To address whether sequence identity influenced the process of resolu-
tion we created an intratypic type 3/3 equivalent of #105B, designated #PV3-105B (Fig 2A), in
which the duplicated viral sequences were all from poliovirus type 3. If sequence identity was a
positive influence on resolution, we expected to see an increased rate of resolution for #PV3-
105B when compared to #105B. Contrary to this expectation, we found that #PV3-105B
resolved slower than #105B (Fig 2C). #PV3-105B also exhibited higher peak virus titres com-
pared to #105B (Fig 2B). As we have previously demonstrated that resolution selects for
increasingly fit viruses [10] we conclude that the slower resolution rate of #PV3-105B is a con-
sequence of initial increased fitness, with concomitant reduced selection pressure for better
replicating variants. Although this confirmed that resolution is primarily a fitness-driven pro-
cess, the differing replication rates meant we could not conclusively rule out a role for
sequence identity in the process.
The gradual appearance of lower molecular weight products over the course of #105B and
#PV3-105B passaging, leading to wild type length genome populations supports a sequential
resolution process, as previously suggested [10], with some intermediate products being non-
viable. To investigate these, we employed ONT sequencing of amplicons generated from virus
supernatant from a passaged resolving virus population. Although the long read-length of
nanopore technology allowed analysis of the entire amplicon, the inherent high error rate
necessitated the development of a novel analysis pipeline. We generated a database in silico
that contained all 14,209 potential in-frame resolving and resolved genomes that could be
present in supernatant, and used these as templates for alignment of ONT reads and the gener-
ation of variant consensus sequences (S1 Fig).
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We identified a relatively small number of recombinant variants in total, 15 for #105B and
4 for #PV3-105B (Fig 3). We observed that the ONT analysis was sensitive to the threshold
(number of reads to generate a consensus) used to define a junction (S1 Fig); reducing the
threshold increased the range of junctions predicted, but introduced results potentially influ-
enced by the template matched and the inherent high error rate of the technology. As the latter
improves, the long ONT read lengths will likely offer the exciting potential for whole-genome
recombination analysis.
One of the most interesting observations in the analysis of the #105B ONT data was the
overlap observed in the variants isolated between different passaging replicates (Fig 4). The
question arises as to whether these variants are (a) generated more readily or (b) have a fitness
advantage, and therefore are amplified faster to detectable levels in the population. If resolu-
tion is a fitness driven process, then we would assume the latter. Resolved variant PV33378 was
detected in both replicates at all passages analysed (Fig 4), with the greatest number of consen-
sus sequences (S3 Fig), and therefore reads, generated, suggesting that this precise recombi-
nant has a selective advantage. However, in direct competition assays with cloned
recombinant PV33399 –a resolved variant detected less frequently and at lower levels–no fitness
advantage was observed for cloned PV33378 (S6 Fig). This implies that more complex popula-
tion dynamics are at play than can be determined by the sensitivity of such an assay.
Our ONT analysis of resolving viral genomes likely represented only a subset of the RNA
variation present within the cell cytoplasm [13]. We therefore investigated the latter using Illu-
mina next generation sequencing and observed significant levels of diversity within the RNA
population (Figs 5A and S4). Based on the RNA population diversity observed at p0 via Illumina
sequencing a large number of genome variants are generated immediately following transfection
of a clonal RNA template (Fig 5A). Would the same infectious recombinants arise each time
from different p0 RNA samples? We would expect this to be the case if those particular interme-
diates have advantages, either in their creation or their subsequent propagation, and would be
an interesting topic for further study. We have shown that under the same passaging conditions
parallel replicates generate similar resolving populations (Figs 4 and S3). However, altering those
conditions–for example the volume of supernatant taken for subsequent passages–can influence
the resolution process, as observed in the differences between the rate of resolution between the
ONT and Illumina data sets. The viable variant population is therefore likely to be a result of
both the input virus population and the stochasticity of the resolution process.
As recently demonstrated for recombination [13], viruses undergoing resolution generate
an extensive population of diverse molecules (S4 Fig), the identity of which could arise from
additional in trans polymerase-mediated template switching events. If that were the case, we
would expect resolution to be influenced by factors known to influence recombination per se.
Additionally we would also expect to be able to identify specific in trans crossover products
with a suitable experimental system.
To test this hypothesis further we repeated the passaging of #105B in the presence of sub-
lethal doses of ribavirin and analysed the resolving populations by gel electrophoresis (Fig 6).
It is now well established that reduced polymerase fidelity results in increased error frequen-
cies, which, in turn, is linked to an increase in recombination and correlates with recombina-
tion being a driving force behind virus evolution and avoidance of error-catastrophe-based
population decline. By recapitulating this increased error rate through the use of ribavirin we
observed an increase in resolution up to and including in the presence of 200 μM ribavirin,
supporting our hypothesis that the mechanism underpinning resolution is further rounds of
recombination.
Poliovirus polymerase mutations rates, both intrinsic and in the presence of mutagens such
as ribavirin, have been well-studied [21,36–38]. Crotty et al. [21] demonstrated that the
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mutation rates for poliovirus were increased from 2.1 per 10,000 nt to 2.5- and 9.3 per 10,000
nt in the presence of 100 μM and 400 μM ribavirin respectively–a range which encompasses
the concentrations used in our study. Such an increase in the overall mutation rate may also
increase the occurrence of point mutations elsewhere in the genome that are beneficial to the
virus. Resolution may therefore be driven by selection of those variants that are lacking in
duplications but also containing point mutations that improve virus fitness.
Notwithstanding this evidence, it remained possible that resolution occurs via a novel
mechanism such as in cis deletion events. By its very nature recombination requires two repli-
cating genomes but, only when there are differences between those two genomes can recombi-
nation be identified. To discriminate between in cis deletion and in trans recombination
events during the resolution of #105B we engineered unique ‘barcodes’ into two copies of
#105B genome (Fig 7) and passaged each virus in the presence of wild type #105B. Analysis of
the resolving virus populations identified recombination events between barcoded and non-
barcoded #105B genomes (Fig 8) in 15% of the progeny analysed. Of these, the two junctions
identified in the three variants #105B/T23420, #105B/T2Δ207 and #T1/105BΔ207, had been
observed previously (Fig 3A and 3C) supporting our theory that a select few recombinants
with a replication advantage are likely to colonize a host.
Presuming recombination occurs during negative strand synthesis [4] the 30 genome
sequence can be regarded as being derived from the donor template, with the 50 sequence
derived from the acceptor. By its nature the CRE-REP assay could only generate viable
genomes with a 50 PV3 and 30 PV1, and therefore it was not possible to establish if there was an
inherent bias for templates to act as a donor or an acceptor. In the analysis of the barcoded
recombinants we observed templates acting as both donor and acceptor based on the orienta-
tion of the 50 and 30 barcode sequences, with 5 examples of #105B as the donor and 4 examples
of #105B as the acceptor, thus demonstrating, albeit with a limited number of samples, no
obvious bias in the directionality of recombination as we have previously indicated [13].
It is clear, though perhaps unsurprising, that the resolution process can and does involve
further rounds of recombination that necessitates an in trans strand transfer event. An iterative
recombination process also explains the presence of out-of-frame recombinants continually
detected throughout passaging of #105B (Fig 5C). Such junctions are possible when template-
switching events occur at either position 1 or 2 of any individual codon and will be generated
anew with each passage. However, as out-of-frame genomes will not go on to produce infec-
tious progeny virions, and as shown in this study (Fig 5A), the relative percentage in the popu-
lation will eventually be surpassed by the fitter, and replication competent, in-frame genomes.
While the evidence highlights a role for in trans template-switching events, it remains
unclear as to whether in cis events are also driving the evolution of viruses with imprecise
genomes. Ongoing studies investigating the behaviour of polymerases during RNA synthesis
suggests that both in trans template-switching, and in cis copy-back type recombination events
can occur [39,40], and such research may offer valuable insights into our further understand-
ing of this fundamental process.
Materials and methods
Virus and cell culture
HeLa cells were maintained at 37˚C, 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM;
Sigma) supplemented with 10% heat-inactivated FBS (FBS-DMEM; Life Technologies). Polio-
virus type 1 (Mahoney), type 3 (Leon) and recombinant pT7-#105B were recovered following
transfection of an in vitro transcribed RNA from full-length cDNA and virus stocks quantified
by plaque assay on HeLa cells. Growth kinetics of viruses were determined following infection
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of HeLa cells at a multiplicity of infection (MOI) of 5 in serum-free media (SF-DMEM). Unab-
sorbed virus was removed by washing with PBS and cells incubated in fresh FBS-DMEM at
37˚C, 5% CO2. Supernatants containing virus were harvested at various time points post-infec-
tion and quantified by plaque assay on fresh monolayers of HeLa cells.
Serial passaging
Unless otherwise stated, for serial passaging HeLa cells were seeded at 1x105 cells/well in
12-well plates 18 h prior to infection. To generate passage 1, stock virus was infected at MOI 1,
assuming a cell density upon infection of 5x105, for 1h at 37˚C, 5% CO2, and cells overlaid
with 1mL/well FBS-DMEM. Supernatants were harvested at 8 h post-infection during early
signs of CPE and 250 μL of each 1 mL supernatant was used to infect fresh monolayers of
HeLa cells, as above, for subsequent passages.
in vitro RNA transcription and transfection
PV1 and #105B variant plasmids were linearized with ApaI, and PV3 linearized with SalI, and
RNA transcribed using a HiScribe T7 High Yield RNA Synthesis kit (NEB) following the man-
ufacturers’ protocol. RNA transcripts were DNaseI (NEB) treated to remove residual template
DNA and column purified using a GeneJET RNA Purification kit (ThermoFisher) prior to
spectrophotometric quantification. For virus stocks, 1 μg of RNA was transfected into 80%
confluent HeLa cell monolayers using Lipofectamine 2000 (Life Technologies) in a 3:1 Lipofec-
tamine 2000:RNA ratio as per manufacturers’ protocol. Virus supernatant harvested 24 h post-
transfection and quantified by plaque assay on HeLa cells.
Synthesis and infection of barcoded #105B
The region of #105B in which resolution could occur to yield a precise genome (resolution
window) is located from nt 3361 to nt 3720 of #105B. Five amino acids, with maximum coding
redundancy, were selected flanking either side of this region: 50-PV3_VP1 Pro277, Gly280,
Pro281, Gly282, Val283 and, 30-PV1_2A Leu39, Leu40, Val41, Thr42, Ser44. A geneblock
library was synthesised (IDT) with an n at the 3rd base position of each amino acid. Addition-
ally, Leu40 was altered from TTA > CTn to ensure maximum redundancy without altering
the amino acid. Individual DNA fragments were used to replace the equivalent WT sequence
in pT7-#105B using HiFi Builder cloning technology (NEB). Colonies were screened and
sequenced and two plasmids containing unique and divergent sequences were selected as pT7-
#105BT1 and pT7-#105BT2.
HeLa cells were seeded at 5 x 105 per well in 6-well plates 18 h prior to assay. Cells were co-
infected with virus inoculum at a final MOI 10 for 30 min at 37˚C. Inoculum was removed
and cells washed once with PBS. Fresh media was added and cells incubated for a further 8 h at
37˚C, 5% CO2. Virus-containing supernatant was harvested and quantified by plaque assay on
fresh HeLa cells prior to subsequent passage at MOI 10. RNA was extracted from viral super-
natants at passages 7 and 9 and the resolution window amplified by RT-PCR as described
below. PCR products were cloned using the pGEM-T Easy System (Promega) and sequence
determined by Sanger sequencing (Eurofins Genomics, Germany) with primer VP1(F): 50-
GGTGTATTGGCAGTTCGTGTTG.
RNA extraction and RT-PCR
Viral RNA was isolated from clarified cell culture supernatants using an Omega Total RNA
Isolation Kit 1 (Omega BioTek, VWR) and reverse transcribed at 42˚C using an oligo dT
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primer and SuperScript II reverse transcriptase (Life Technologies) as per manufacturers’ pro-
tocol. The resolution window was amplified using standard Taq polymerase (NEB) with an ini-
tial denaturing at 95˚C for 30 sec, followed by 30 cycles of 95˚C for 30 sec, 50˚C for 30 sec and
68˚C for 90 sec, and a final extension at 68˚C for 5 min with primers PV3(F): 50-GCAAACAT
CTTCCAACCCGTCC and PV1(R): 50-TTGCTCTTGAACTGTATGTAGTTG, or PV3-IS(F):
50-CCCAAACACGTACGTGTCTG and PV1-IS(R): 50-TGTATCCGTCGAAGTGTGATGG
for Illumina sequencing. PCR products were separated by 1% agarose gel electrophoresis and
sequence determined by Sanger sequencing (Eurofins Genomics, Germany). Sequence analysis
was completed using SnapGene, Version 4.0.8. Illumina sequencing was carried out and ana-
lysed as previously described [13].
Ribavirin treatment
HeLa cells were seeded at 2 x 105 per well in 12-well plates and infected with #105B at MOI 1
for 30 min. Cells were washed with PBS and fresh media added to all wells. Ribavirin was
added to a final concentration of 0, 50, 100 or 200 μM and cells incubated for 24 h. Virus was
subsequently blind passaged by infecting fresh monolayers of HeLa cells with a 1:4 dilution of
supernatant from the previous passage, with Ribavirin added as above. At each passage, RNA
was extracted from viral supernatants and the resolution window amplified by RT-PCR as
described above.
Next generation sequencing library preparation and sequencing
Viral RNA was extracted from serially passaged #105B and #PV3-105B virus supernatants and
reverse transcribed as described above. For Illumina sequencing, samples were prepared and
reads analysed as described in [13].
For Oxford Nanopore Technologies (ONT) analysis, primers for the initial PCR amplifica-
tion of the resolution window, were adapted to include the Oxford Nanopore adaptor
sequence and reactions cycled as described above. PCR products were purified using a Wizard
SV Gel and PCR Clean-up System (Promega). Samples were barcoded using Oxford Nanopore
PCR barcodes (EXP-PBC001) as per manufacturer’s protocol. PCR products were purified as
above and quantified on a NanoDrop ND1000. Amplicons were pooled in desired ratios (S1
Table) with a total of 1 μg of amplicons used to create a DNA library. Library construction was
carried out as per Oxford Nanopore protocol SQK-LSK109. The library was run on a FLO-
MIN106 flow cell primed as per protocol SQK-LSK109 with reads collected over an 8 h period.
Oxford Nanopore Technologies sequence data processing
Raw fast5 files were basecalled and de-multiplexed using ONT Albacore Pipeline software (v
1.2.4). Passed reads were converted to FASTA format using the extract command in Nanopol-
ish (v 0.6.1) [41].
A variants database was created of 14,209 potential in-frame, resolved/resolving sequences
within the resolution window. ONT reads were screened against the variants database using
Blastn. Reads with<90% sequence identity to a potential variant, and that were +/-10% of the
min/max possible length of the PCR product, were removed. Remaining reads were extracted
and ordered based on each potential variant and all the ONT reads which matched to it.
Aligned reads were processed using Nanopolish to generate consensus sequences against best
matched potential variants. A cut-off limit was applied, where only template matches which
contained >100 ONT reads were processed to generate a consensus sequence. Using Nanopol-
ish, all generated consensus sequences were verified as in-frame and confirmed as matching
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the best potential variant template. A recombinant was defined as true if�10 identical consen-
sus sequences were generated. Scripts available on request.
Supporting information
S1 Fig. Oxford Nanopore Technologies sequencing analysis pipeline. Flowchart shows each
step taken to generate recombinant sequences from Oxford Nanopore sequencing data. Boxes
represent processes in the pipeline, diamonds represent decision points and ovals represent
termination points.
(TIF)
S2 Fig. Sequences of recombinant junctions identified from nanopore analysis. Sequences
denote the 30 nt spanning the junction of individual #105B (A) or #PV3-105B (B) resolving
recombinants (designation in upper left corner). Uppercase sequences distinguish PV3 derived
sequence from PV1 replicon derived sequence with numbers denoting the genome positions
relative to full length PV3 and PV1. Numbers in the upper right corner indicate the number of
additional nucleotides present in the recombinant genome, while underlined nucleotides indi-
cate the reading-frame of the recombinant.
(TIF)
S3 Fig. #105B variant population frequencies. The frequency of each variant within the over-
all population was determined based on the number of consensus sequences generated for
each variant. The number of consensus sequences for each variant was expressed as a percent-
age of the total number of consensus sequences generated at each passage (or pooled passages).
Variants are shown for both Replicate 1 (black) and Replicate 2 (pink) passaging.
(TIF)
S4 Fig. Parallel coordinates visualisation of #105B Illumina recombinants. The location of
each recombination junction was mapped respective to each parental genome. Each line repre-
sents a unique recombinant within the population of precise (black), imprecise-insertion
(blue) and imprecise-deletion (red) recombinants. Each recombinant is shown as in-frame
(1.0) or out-of-frame (0.0) with log10 read count below.
(TIF)
S5 Fig. Shannon entropy diversity of Illumina sequenced resolving #105B populations. The
flattened data was used to calculate Shannon Entropy using the equation
HðXÞ ¼
PN  1
i¼0 Piln pi. The probability of each unique junction was calculated by dividing 1
over the total number of junctions, and plotted against passage number.
(TIF)
S6 Fig. Sanger sequence analysis of competition assays between resolved recombinants.
Sequence trace analysis of the viral population following co-infection and 10 passages of 2
resolved variants, PV33378 and PV33399. Viruses were co-infected at ratios of 1:4 (PV33378:
PV33399) (upper panel), 4:1 (PV33378: PV33399) (middle panel) and 1:1 (bottom panel) with
traces showing the population sequence at p10. Grey boxes highlight the different nucleotides
between PV33378 and PV33399 used to determine the dominant sequence in the population.
(TIF)
S1 Table. Oxford Nanopore Technologies Library and Reads.
(DOCX)
S2 Table. Oxford Nanopore Variant Junctions.
(DOCX)
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S3 Table. Barcoded #105B Variants.
(DOCX)
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